An alternative regimen to reduce risk of asthma exacerbations
Loading...
Authors
Meeting name
Sponsors
Date
Journal Title
Format
Article
Subject
Abstract
An alternative regimen to reduce risk of asthma exacerbations This study supports the use of an ICS/LABA as needed for adults with intermittent, mild persistent, and moderate persistent asthma. Practice changer: PRACTICE CHANGER Use an inhaled corticosteroid plus long-acting beta-agonist (ICS/LABA) prn for intermittent, mild persistent, or moderate persistent asthma for fewer moderate and severe exacerbations and the same daily symptom control as scheduled ICS with a short-acting beta-agonist (SABA) prn. STRENGTH OF RECOMMENDATION A: Based on a single, good-quality, multicenter, randomized controlled trial.
Table of Contents
DOI
PubMed ID
Degree
Thesis Department
Rights
OpenAccess.
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.